NTRR Forms New Cannabis Subsidiary to Capitalize on Booming Billion-Dollar Cannabis Market

Updated

NTRR Forms New Cannabis Subsidiary to Capitalize on Booming Billion-Dollar Cannabis Market

SARASOTA, Fla.--(BUSINESS WIRE)-- Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural health remedies, announced today that it's forming a new subsidiary—Cannabis Technologies, Inc.—to engineer the company's entry into the billion-dollar medical marijuana (MMJ) market.

Medicinal cannabis is a big business that's getting bigger every day—potentially rising to $6 billion by 2018, according to a new study released by Colorado-based MMJ Business Daily. Prescription cannabis is currently available in 18 states and Washington, D.C., with 11 more states considering legislation to legalize the drug for medical use.


NTRR is working to capitalize on that growth by seeking out new, emerging partners ready to develop and market innovations in the processing and use of cannabis-derived nutraceutical treatments for illnesses from cancer and arthritis to simple headaches and insomnia. Cannabis Technologies, Inc., will soon be placed in charge of those efforts, while the parent company pursues equally promising opportunities in other sectors, including the multi-billion dollar "green hygiene" industry.

To that end, the company signed an option with Purlife Distributors, Inc., the exclusive Canadian distributor of a patent-pending water-based solution that forms an invisible, long-lasting coating that actively protects surfaces from the build-up of bacteria, molds, germs and allergens.

Through its new Los Angeles-based MMJ subsidiary, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA) and Terra Tech Corp. (PINK: TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR's initiatives, please visit www.neutracorp.com/investors.html.

Follow NTRR on Twitter at www.twitter.com/neutracorp.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.



Neutra Corp.
Cindy Morrissey, 713-821-1486
President and CEO
info@neutracorp.com

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS:

The article NTRR Forms New Cannabis Subsidiary to Capitalize on Booming Billion-Dollar Cannabis Market originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement